Three Tier Screening Tool and Second Triage to Minimize the Spread of COVID-19 in Emergency Department of a Tertiary Hospital in India

Introduction: Since the outbreak of Coronavirus on December 31, 2019 in Wuhan, Hubei Province, People’s Republic of China, the number of cases from China that have been imported into more than 180 countries and regions around the world. Objective: The goal of this study is to flatten the curve of new infection, through nosocomial transmission by health care system along with early identification of asymptomatic COVID-19 cases. Methods: A Survey was conducted over a period of 35 days. A total of 1709 individuals were screened (647 patients and 1062 patient attendees) coming to emergency Department. The waiting area of Emergency Care was divided into 3 screening zones and a separate second triage is established. The individuals entering are ensured that they are screened at all the 3 zones. Individuals were divided into two Groups after screening: Group A (suspected COVID-19) and Group B (unsuspected COVID-19). In Acute emergencies, the patient was directly treated at second triage. Results: A total of 1709 individuals, 247 in Group A (Suspected COVID-19) and 1462 in Group B (Unsuspected COVID-19). Among 247 individuals, 141 were males and 106 were females. Age ranged from 14-72 years with a mean age of 46.7years. Among 247 individuals (Group A), 81 were patients, of which one case was found to be COVID-19 Positive. Two Health care workers (HCW’s) found to be positive. Conclusion: Challenges from the widespread pandemic underscores the importance of early implementation of a second triage and vigorous screening for all the individuals to minimize the spread of infection, failing which pandemic infection may turn into an epidemic

A study on Adverse Effects Following Immunization (AEFI) following Covishield Vaccination among Health Care Workers at Tertiary Health Care centre.

The AstraZeneca’s Covisheild vaccine against COVID-19 was rolled out in several parts of the world and approved for emergency authorisation in India from 16th January 2021. Real-time post vaccination experience outside the manufacturers vaccine trial is bizarre and not well documented. Knowledge about adverse events following Covisheild vaccine will educate the people, allay their fears, stigma and lower their hesitancy towards vaccination. The aim of our study is to identify the adverse events following Covisheild vaccination in health care workers (HCW’S) at TIMS. Methods: A cross-sectional, observational survey was conducted to study the adverse events following Covisheild immunisation drive among the HCW’S at TIMS from 19th January to 9th March 2021. Results: The acceptance of vaccine among the HCW’S was 60 %. The frequency of incidence of AEFI was significantly less following 2nd dose when compared to 1st dose (p<0.005). Post-vaccination symptoms were more likely reported in women (57.24%) compared to men (56.10%) (p> 0.05). Incidence of AEFI within 30 minutes was significantly higher among females than males (p=0.027). AEFI persisted for a longer duration upto 72hrs among females than males and this difference was statistically significant (p=0.001). Conclusion: Majority of the reported AEFI were, mild, self-limiting, of short duration and none were serious. No hospitalisation was required and nil fatality was observed. This guides the individual to accept the national covid -19 vaccination drive, which is the most crucial step to halt this deadly pandemic. Acceptance and immunisation is crucial to achieve herd immunity to curb this pandemic